Burden of illness in Italian patients with gastro-oesophageal reflux disease

Current Medical Research and Opinion

Volumn 21, Issue 4, 2005, Pages 495-502

  Pacini, Franco ^a   Calabrese, Carlo ^b   Cipolletta, Livio ^c   D'Ayala Valva, Mario ^d   Russo, Antonio ^e   Savarino, Vincenzo ^f   Vigneri, Sergio ^g  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Dipartimento di Medicina Interna   (Italy)

^c Torre del Greco   (Italy)

^d Servizio di Gastroenterologia Ospedale SS Annunziata   (Italy)

^e Cattedra di Gastroenterologia Policlinico   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g II Clinica Medica Interna di Geriatria Policlinico   (Italy)

Author keywords

Burden of illness; Health related quality of life; Heartburn; Italy

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; DISEASE SEVERITY; EMOTION; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM RATING SCALE; HEARTBURN; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INDIGESTION; ITALY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; QUALITY OF LIFE; QUALITY OF LIFE IN REFLUX AND DYSPEPSIA QUESTIONNAIRE; QUESTIONNAIRE; RATING SCALE; SELF REPORT; SHORT FORM 36; SLEEP DISORDER; SYMPTOM; THORAX PAIN;

ADULT; AGED; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EMOTIONS; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH STATUS; HUMANS; ITALY; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS;

EID: 18744403099     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X38231     Document Type: Article

References (60)

1. Dent J, Brun J, Fendrick AM, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ, on behalf of the Genval Workshop Group. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999;44(Suppl 2):S1-16
2. Jones RH, Hungin AP, Phillips J, Mills JG. Gastro-oesophageal reflux disease in primary care in Europe: clinical presentation and endoscopic findings. Eur J Gen Pract 1995;1:149-54
3. Napierkowski J, Wong RK. Extraesophageal manifestations of GERD. Am J Med Sci 2003;326:285-99
4. Jaspersen D, Kulig M, Labenz J, Leodolter A, Lind T, Meyer-Sabellek W, Vieth M, Willich SN, Lindner D, Stolte M, Malfertheiner P. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Alimen Pharmacol Ther 2003;17:1515-20
5. El-Serag HB, Gilger M, Kuebeler M, Rabeneck L. Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology 2001;121:1294-9
6. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-56
7. Stangheilini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/ International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999;231:20-8
8. Valle C, Broglia F, Pistorio A, Tinelli C, Perego M. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci 1999;44:1848-52
9. Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 1996;183:217-24
10. Moyer CA, Fendrick AM. Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis 1998;16:315-24
11. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, Lind T, Meyer-Sabellek W, Malfertheiner P, Stolte M, Willich SN. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003;18:767-76
12. Shaw MJ, Crawley JA. Improving health-related quality of life in gastro-oesophageal reflux disease. Drugs 2003;63:2307-16
13. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9
14. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998;2:1-74
15. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001;96:1998-2004
16. Kaspari S, Biedermann A, Mey J. Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease. Digestion 2001;63:163-70
17. Prasad M, Rentz AM, Revicki DA. The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review. Pharmacoeconomics 2003;21:769-90
18. Wiklund I. Quality of life in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001;96:S46-53
19. Kulich KR, Calabrese C, Pacini F, Vigneri S, Carlsson J, Wiklund IK. Psychometric validation of the Italian translation of the Gastrointestinal Symptom-Rating Scale and Quality of Life in Reflux and Dyspepsia Questionnaire in patients with gastro-oesophageal reflux disease. Clin Drug Invest 2004;24:205-15
20. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, Mitchell B, Beveridge BR, Laurence BH, Gibson GG, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12
21. Dimenäs E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046-52
22. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Pare P, Chiba N, Leddin DS, Bigard MA, Colin R, Schoenfeld P. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998;583:41-9
23. Crawley J, Frank L, Joshua-Gotlib S, Flynn J, Frank S, Wiklund I. Measuring change in quality of life in response to Helicobacter pylori eradication in peptic ulcer disease: the QOLRAD. Dig Dis Sci 2001;46:571-80
24. Wahlqvist P, Carlsson J, Stalhammar NO, Wiklund I. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)-results from a cross-sectional study. Value Health 2002;5:106-13
25. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83
26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70
27. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998;51:1025-36
28. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998;7:75-83
29. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-reported outcomes: The example of health-related quality of life - A European guidance document for the improved integra-tion of health-related quality of life assessment in the drug regulatory process. Drug Inf J 2002;36:209-38
30. Wiklund I, Talley NJ. Update on health-related quality of life in patients with gastroesophageal reflux disease. Expert Rev Pharmacoeconomics Outcomes Res 2003;3:341-50
31. Kulich KR, Pacini F, D'ayala Valva M, Calabrese C, Galeazzi R, Cipolletta L, Rizzetto M, Dughera L, Saggioro A, Capruso L, Di Febo G, Savarino V, Vigneri S, Zambelli A, Russo A, Carlsson J, Wiklund I. Psychometric validation of the Italian translation of Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease. Clin Drug Invest 2004;24:205-15
32. Kulich KR, Wiklund I, Junghard O. Factor structure of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire evaluated in patients with heartburn predominant reflux disease. Qual Life Res 2003;6:699-708
33. Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of life Assessment. J Clin Epidemiol 1998;51:1159-65
34. Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M, Thunedborg K. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1167-70
35. Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, Robertson B, Bliss J. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 1991;158:255-9
36. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res 1997;42:17-41
37. Drummond HE, Ghosh S, Ferguson A, Brackenridge D, Tiplady B. Electronic quality of life questionnaires: a comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study. Qual Life Res 1995;4:21-6
38. Miller RG. Simultaneous statistical inference, 2nd edn. New York: Springer-Verlag, 1981
39. Halling K, Långström G, Wiklund I: Handling missing data in quality of life questionnaires: Experience from clinical trials, 6th Annual Conference of the International Society for Quality of Life Research. Barcelona, Spain, 1999
40. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, McGlynn EA, Ware Jr JE. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989;262:907-1013
41. Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999;231:48-54
42. Contini S, Bertele A, Nervi G, Zinicola R, Scarpignato C. Quality of life for patients with gastroesophageal reflux disease 2 years after laparoscopic fundoplication. Evaluation of the results obtained during the initial experience. Surg Endosc 2002;16:1555-60
43. Madisch A, Kulich KR, Malfertheiner P, Ziegler K, Carlsson J, Wiklund I. Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany. Z Gastroenterol 2003;41:1137-43
44. Pique JM, Kulich KR, Vegazoc O, Jimenez J, Zapardiel J, Carlsson J, Wiklund I. Burden of gastroesophageal reflux disease. Evidence from a recent methodological study in Spain. Gastroenterol Hepatol 2004;27:300-6
45. Ujszaszy L, Kulich RK, Toth GT, Barany L, Carlsson J, Wiklund I. Burden of illness in patients with reflux disease - evidence from a recent comparative methodological study in Hungary. Orvosi Hetilap 2004;145:717-22,733-8
46. Gallup Organization: Understanding Heartburn in America, 2001
47. Talley NJ, Junghard O, Wiklund IK. Why do patients with gastroesophageal reflux disease have a poor health-related quality of life? Gastroenterology 2001;120(Suppl):A423 [Abstract S1585]
48. Leodolter A, Kulig M, Nocon M, Vieth M, Linder D, Labenz J, Jespersen D, Lind T, Meyer-Sabellek W, Willich SN, Stolte M, Malfertheiner P. Esomeprazole therapy improves sleep disorders in patients with gastroesophageal reflux disease (GERD): a report from the ProGerd study. Digestive Disease Week (DDW), Orlando, Florida 2003;124(Suppl 1):A-226 [Abstract S1585]
49. Kamolz T, Bammer T, Wykypiel Jr H, Pointner R. Stressverarbeitung und Personlichkeitsstruktur bei Patienten mit und ohne stressassoziierter Symptomatik der gastroosophagealen Refluxkrankheit. Z Gastroenterol 1999;37:265-70
50. Bradley LA, Richter JE, Pulliam TJ, Haile JM, Scarinci IC, Schan CA, Dalton CB, Salley AN. The relationship between stress and symptoms of gastroesophageal reflux: The influence of psychological factors. Am J Gastroenterol 1993;88:11-9
51. Kulig M, Leodolter A, Schulte E, Vieth M, Jaspersen D, Labenz J, Lind T, Meyer-Sabellek W, Stolte M, Malfertheiner P, Willich SN. Quality of life in patients with gastroesophageal reflux disease. Qual Life Res 2002;11:649
52. Revicki DA, Wood M, Maton PN, Sorensen S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998;104:252-8
53. Kulig M, Leodolter A, Vieth M, et al. Quality of life in patients with gastroesophageal reflux disease. Qual Life Res 2002;11:A111
54. Lind T, Havelund T, Glise H, Hernqvist H, Lauritsen K, Lundell L, Pedersen SA, Wiklund I. Omeprazole improves quality of life in patients with endoscopy negative reflux disease. Gastroenterology 1995;108:A151
55. Wiklund I, Talley N. Update on health-related quality of life in patients with gastroesophageal reflux disease. Expert Rev Pharmacoeconomics Outcomes Res 2003;3:341-50
56. Jones R, Bytzer P. Review article: acid suppression in the management of gastro-oesophageal reflux disease - an appraisal of treatment options in primary care. Aliment Pharmacol Ther 2001;15:765-72
57. Lauritsen K, Junghard O, Wiklund IK. The effect of esomeprazole 40 mg on healing, reflux symptoms and quality of life in patients with reflux esophagitis. Gastroenterology 2002;122:A200
58. Wiklund I, Hansen ÅN, Bergenheim R, Moum B. Esomeprazole is superior to ranitidine 150 mg bid in maintaining quality of life (QoL) in patients with symptomatic GERD, The XXXV Nordic Meeting of Gastroenterology. Helsinki, Finland, 2003
59. Bytzer P. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients. Am J Gastroenterol 2003;98:S31-9
60. Quigley EM. Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003;98:S24-30